Compare CTIC to:
After Hours:
1.10
-0.01 (-0.90%) 4:18pm ET
| Last Trade: | 1.11 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 1.10 |
| Open: | 1.05 |
| Bid: | N/A |
| Ask: | 1.10 x 5000 |
| 1y Target Est: | 2.00 |
| Day's Range: | 1.04 - 1.12 |
|---|---|
| 52wk Range: | 0.05 - 2.23 |
| Volume: | 9,024,524 |
| Avg Vol (3m): | 17,893,800 |
| Market Cap: | 637.61M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.39 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | CELL THERAPEUTICS INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Other EventsEDGAR Online |
| Tue, Nov 24 | Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care ConferencePR Newswire |
| Mon, Nov 23 | A Big Upgrade for Allos Therapeuticsat Motley Fool |
| Fri, Nov 20 | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research AnalystWall Street Transcript |
| Fri, Nov 20 | Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash GroupPR Newswire |
| Wed, Nov 18 | Judges: Seattle biotech can pursue $23M claimAP |
| Mon, Nov 16 | CELL THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online |
| Mon, Nov 16 | Poniard's CEO Pulls a Belichik: BioBuzzat TheStreet.com |
| Mon, Nov 16 | Poniard's CEO Pulls a Belichick: BioBuzzat TheStreet.com |
| Mon, Nov 16 | A Closer Look at Cardium's Wound-Healing Drug: BioBuzzat TheStreet.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.